Letters Screening for prostate cancer Public Health England advice on PSA testing BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3796 (Published 12 July 2016) Cite this as: BMJ 2016;354:i3796 Article Related content Metrics Responses Peer review Related articles Analysis Screening for prostate cancer: time to put all the data on the table Published: 25 May 2016; BMJ 353 doi:10.1136/bmj.i2574 Letter PHE guidance does warn about PSA testing Published: 05 August 2016; BMJ 354 doi:10.1136/bmj.i4238 See more Prostate cancer: Could polygenic risk scores make national screening a reality? BMJ April 15, 2025, 389 r763; DOI: https://doi.org/10.1136/bmj.r763 NICE recommends “targeted” drug capivasertib for advanced breast cancer BMJ April 14, 2025, 389 r762; DOI: https://doi.org/10.1136/bmj.r762 Cancer: People in UK’s poorest areas have longer waits for care and higher death rates BMJ February 21, 2025, 388 r367; DOI: https://doi.org/10.1136/bmj.r367 Hospitals are urged to learn from case of delayed cancer diagnosis after failure to follow up BMJ February 06, 2025, 388 r264; DOI: https://doi.org/10.1136/bmj.r264 Calcium rich diet could reduce bowel cancer risk, study finds BMJ January 08, 2025, 388 r42; DOI: https://doi.org/10.1136/bmj.r42 Cited by... PHE guidance does warn about PSA testingFulltext PDF Authors reply to KoleFulltext PDF
